Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Good Flow: 2021 Updates in Vasculitis

Jason Liebowitz, MD, FACR  |  December 6, 2021

During the ACR Convergence 2021 annual Review Course, Peter Merkel, MD, MPH, provided recent updates on vasculitis.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsMeeting ReportsVasculitis Tagged with:ACR Convergence 2021

Bethany Marston, MD, Assumes Chair of Committee on Rheumatology Training & Workforce Issues

Gretchen Henkel  |  December 6, 2021

Noting that the pandemic has shifted what and how rheumatology trainees learn, Dr. Marston hopes the Committee on Rheumatology Training & Workforce Issues can work to understand current workforce needs and explore new educational opportunities.

Filed under:Education & TrainingProfiles Tagged with:Bethany MarstonCommittee on Rheumatology Training and Workforce IssuesWorkforce

Natasa Adzic / shutterstock.com

ACR Town Hall Offers Research, Tips on Physician Burnout

Renée Bacher  |  December 6, 2021

Physician burnout takes a toll not just on providers, but on their patients and practices as well. Speakers at a recent ACR town hall provided research-based tips to help address the root causes of burnout.

Filed under:American College of RheumatologyProfessional Topics Tagged with:Allen AnandarajahChristine Sinskyphysician burnoutProfessional Topics

Tofacitinib Yields Rapid & Sustained Improvement in JIA

Reuters Staff  |  December 3, 2021

NEW YORK (Reuters Health)—Tofacitinib significantly reduces the number of flares in children with polyarticular course juvenile idiopathic arthritis (JIA), according to the first phase-3 clinical trial to assess the efficacy of a Janus kinase (JAK) inhibitor in JIA. JIA is a heterogeneous group of chronic conditions with no known cause that develop before age 16…

Filed under:ConditionsRheumatoid Arthritis Tagged with:flareJIAjuvenile idiopathic arthritis (JIA)Tofacitinib

In the Thick of It: Scleroderma Update 2021

Jason Liebowitz, MD, FACR  |  December 2, 2021

Laura Hummers, MD, MSc, provided an update on the extra-pulmonary manifestations of scleroderma & the best ways to approach management of these issues.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Sclerosis Tagged with:ACR Convergence 2021

Heart to Heart: Cardiovascular Disease in Autoimmune Conditions

Jason Liebowitz, MD, FACR  |  December 2, 2021

During the ACR Convergence 2021 Review Course, Joan Bathon, MD, discussed cardiovascular manifestations of autoimmune diseases, including rheumatoid arthritis.

Filed under:ACR ConvergenceConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2021ACR Convergence 2021 – RACardiovascular disease

From Strength to Strength: Idiopathic Inflammatory Myopathy Diagnosis & Management

Jason Liebowitz, MD, FACR  |  December 2, 2021

During the ACR Convergence 2021 Review Course, Rohit Aggarwal, MD, MS, provided an update on idiopathic inflammatory myopathy.

Filed under:ACR ConvergenceConditionsMeeting ReportsMyositisOther Rheumatic Conditions Tagged with:ACR Convergence 2021myositis

Lupus Update 2021: Classification Criteria, Disease Activity Measures & More

Jason Liebowitz, MD, FACR  |  December 2, 2021

An SLE expert discusses the latest SLE stats, classification criteria, disease activity tracking, drugs & more.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2021ACR Convergence 2021 – SLE

10 Clinical Insights & Rheumatology Pearls Presented at ACR Convergence 2021

Mithu Maheswaranathan, MD  |  December 2, 2021

Practical tips for the diagnosis, evaluation and treatment of a spectrum of conditions commonly encountered in a rheumatology practice are offered.

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisMeeting ReportsProfessional TopicsVasculitis Tagged with:ACR Convergence 2021C-reactive protein (CRP)Clinical PracticeGoutPractice PearlsVasculitis

The State of Clinical Science for Pediatric Rheumatology in 2021

Elizabeth Sloan, MD  |  December 2, 2021

ACR Convergence 2021—The Pediatric Rheumatology Year in Review began with a fascinating talk by Mara Becker, MD, MSCE, a professor of Pediatrics and vice chair of faculty at Duke University School of Medicine, Durham, N.C. Dr. Becker began by describing her search strategy to select high-yield clinical science publications in pediatric rheumatology from the past…

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2021ClinicalCOVID-19JIAMultisystem Inflammatory Syndrome in Children (MIS-C)PediatricPediatric Rheumatologypolyarticular juvenile idiopathic arthritis (JIA)

  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences